| Kaitlyn Gisse, PA | |
|
321 E Warwick Dr, Alma, MI 48801-1013 | |
| (989) 466-3332 | |
| (989) 466-6805 |
| Full Name | Kaitlyn Gisse |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 321 E Warwick Dr, Alma, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780216523 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 5601010222 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center-gratiot | Alma, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mymichigan Medical Center Alma | 3375451404 | 82 |
News Archive
Oncotarget published "Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology" which reported that the authors comprehensively investigated miRNA-193a-3p's mode of action in a panel of human cancer cell lines, with a variety of genetic backgrounds, using 1B3, a synthetic microRNA mimic
Seventy-six top researchers will receive ERC Proof of Concept grants of €150,000 each. This top-up funding is awarded to ERC grantees to explore the innovation potential of their scientific discoveries and bring the results of their frontier research closer to market.
Researchers have developed a novel, easy-to-use system for three-dimensional (3D) reconstruction and examination of tissues at microscopic resolution, with the potential to significantly enhance the study of normal and disease processes, particularly those involving structural changes. The new approach, using conventional histopathological methods, is described in the May issue of The American Journal of Pathology.
Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the U.S. Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.
Atrial fibrillation is a heart disorder that affects more than two million Americans, and is considered a key contributor to blood clots and stroke. Now researchers from North Carolina State University are developing a new computerized catheter that could make the surgical treatment of atrial fibrillation faster, cheaper and more effective - while significantly decreasing radiation exposure related to the treatment.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaitlyn Gisse, PA 1280 E Campus Dr, Mount Pleasant, MI 48858-3803 Ph: () - | Kaitlyn Gisse, PA 321 E Warwick Dr, Alma, MI 48801-1013 Ph: (989) 466-3332 |
News Archive
Oncotarget published "Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology" which reported that the authors comprehensively investigated miRNA-193a-3p's mode of action in a panel of human cancer cell lines, with a variety of genetic backgrounds, using 1B3, a synthetic microRNA mimic
Seventy-six top researchers will receive ERC Proof of Concept grants of €150,000 each. This top-up funding is awarded to ERC grantees to explore the innovation potential of their scientific discoveries and bring the results of their frontier research closer to market.
Researchers have developed a novel, easy-to-use system for three-dimensional (3D) reconstruction and examination of tissues at microscopic resolution, with the potential to significantly enhance the study of normal and disease processes, particularly those involving structural changes. The new approach, using conventional histopathological methods, is described in the May issue of The American Journal of Pathology.
Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the U.S. Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.
Atrial fibrillation is a heart disorder that affects more than two million Americans, and is considered a key contributor to blood clots and stroke. Now researchers from North Carolina State University are developing a new computerized catheter that could make the surgical treatment of atrial fibrillation faster, cheaper and more effective - while significantly decreasing radiation exposure related to the treatment.
› Verified 8 days ago
Kristie Ann Truman, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 315 E Warwick Dr, Suite F-1, Alma, MI 48801 Phone: 989-463-0957 Fax: 989-968-4032 | |
John M Wegner, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 300 E Warwick Dr, Alma, MI 48801 Phone: 989-466-3228 | |
Miss Rojane Swanepoel, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 315 E Warwick Dr, Suite 3, Alma, MI 48801 Phone: 989-463-6699 Fax: 989-466-2574 | |
Matthew Brandon Kanitz, P.A Physician Assistant Medicare: Medicare Enrolled Practice Location: 300 E Warwick Dr, Alma, MI 48801 Phone: 989-466-3275 | |
Maggie Ann Ross, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 614 W Superior St, Alma, MI 48801 Phone: 989-463-7181 Fax: 989-463-7351 | |
Jordan Michael Block, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 300 E Warwick Dr, Alma, MI 48801 Phone: 989-463-1101 | |
Christopher M Mcmahon, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 311 E Warwick Dr, Suite A, Alma, MI 48801 Phone: 989-463-4976 |